Academic Journal
Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis.
Title: | Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis. |
---|---|
Authors: | Bozek A; Clinical Department of Internal Diseases, Dermatology and Allergology in Zabrze, Medical University of Silesia, Katowice, Poland., Kozłowska R; Clinical Department of Internal Diseases, Dermatology and Allergology in Zabrze, Medical University of Silesia, Katowice, Poland., Misiołek M; Department of Otorhinolaryngology and Laryngological Oncology in Zabrze, Medical University of Silesia, Katowice, Poland., Ścierski W; Department of Otorhinolaryngology and Laryngological Oncology in Zabrze, Medical University of Silesia, Katowice, Poland., Gawlik R; Clinical Department of Internal Diseases, Allergology and Clinical Immunology in Zabrze, Medical University of Silesia, Katowice, Poland. |
Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (6), pp. 2097818. Date of Electronic Publication: 2022 Jul 11. |
Publication Type: | Journal Article |
Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
Database: | MEDLINE Complete |
Full text is not displayed to guests. | Login for full access. |
ISSN: | 2164-554X |
---|---|
DOI: | 10.1080/21645515.2022.2097818 |